Genezen, a gene therapy contract development and manufacturing organization (CDMO), has welcomed Dr. Pam Stetkiewicz and Stuart Auerbach to its Board of Directors.   These board appointments bolster Genezen’s strategic growth plan and come at a time of significant momentum for the organization. About Dr. Pam Stetkiewicz Stetkiewicz brings significant gene therapy drug development and CMC experience to Genezen’s Board through her current position as Chief Operating Officer at A...